| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 01/03/2002 | WO2001037884A3 Improved tissue engineered blood vessels and methods and apparatus for their manufacture |
| 01/03/2002 | US20020002194 Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
| 01/03/2002 | US20020001842 Cytoplasmic transfer to de-differentiate recipient cells |
| 01/03/2002 | US20020001841 Continuous t-cell lines |
| 01/03/2002 | US20020001626 Submucosa gel compositions |
| 01/03/2002 | US20020001625 Pharmaceutical or veterinary composition for treating wounds comprising milk product extracts including growth factors with basic to neutral isoelectric points |
| 01/03/2002 | US20020001624 Medicinal product for the promotion of wound healing |
| 01/03/2002 | US20020001596 Prophylactic and therapeutic method |
| 01/03/2002 | US20020001595 Sampling antigen-containing blood and/or tissue; obtaining liquid/homogenate; adding crosslinking agent; heating to solidification; mixing with pyrogen-free salt solution; for treatment of AIDS, HIV |
| 01/03/2002 | US20020001590 Antibacterial therapy for multi-drug resistant bacteria |
| 01/03/2002 | US20020001578 Treatment of disorders by implanting stem cells and/or progeny thereof into gastrointestinal organs |
| 01/03/2002 | US20020001577 Use of cells with the ability to generate excitation within a cell preparation |
| 01/03/2002 | US20020001576 Medicaments containing allogenic activated-CD4+ cells as the main ingradient, which are attributable to an organ or bone marrow implant donor, have extreemly beneficial effect for preventing tumor and various infections |
| 01/03/2002 | US20020000403 Copolymer of an alkoxyalkyl (meth)acrylate and a monomer having a basic functional group; biocompatible surface treatment |
| 01/03/2002 | US20020000372 Dry contact assemblies, methods for making dry contact assemblies, and plating machines with dry contact assemblies for plating microelectronic workpieces |
| 01/03/2002 | CA2413910A1 Cell fractions containing cells capable of differentating into neural cells |
| 01/03/2002 | CA2413800A1 Manipulation of negative stranded rna viruses by rearrangement of their genes and uses thereof |
| 01/03/2002 | CA2413742A1 Prion-binding activity in serum and proteins |
| 01/03/2002 | CA2413543A1 Human papilloma virus treatment |
| 01/03/2002 | CA2413301A1 Methods for using tetanus toxin for benificial purposes in animals (mammals) |
| 01/03/2002 | CA2412637A1 Replication deficient adenoviral tnf vector |
| 01/03/2002 | CA2412621A1 Rescue of canine distemper virus from cdna |
| 01/02/2002 | EP1167379A2 Immunomodulatory oligonucleotides |
| 01/02/2002 | EP1167378A2 Immunomodulatory oligonucleotides |
| 01/02/2002 | EP1167377A2 Immunomodulatory oligonucleotides |
| 01/02/2002 | EP1166793A1 Treatment of neuromuscular disorders and conditions with different botulinum serotype |
| 01/02/2002 | EP1166102A1 Heart abnormalities in vascular endothelial growth factor b (vegf-b) deficient animals and methods relating to these heart abnormalities |
| 01/02/2002 | EP1165830A1 Adipose-derived stem cells and lattices |
| 01/02/2002 | EP1165828A1 50 human secreted proteins |
| 01/02/2002 | EP1165818A2 Therapy of cancer by insect cells containing recombinant baculovirus encoding genes |
| 01/02/2002 | EP1165817A1 Use of helper-dependent adenoviral vectors of alternative serotypes permits repeat vector administration |
| 01/02/2002 | EP1165807A1 A protease, a gene therefor and the use thereof |
| 01/02/2002 | EP1165784A2 Nucleic acids including open reading frames encoding polypeptides; "orfx" |
| 01/02/2002 | EP1165778A2 Casb618 polynucleotides and polypeptides and their use |
| 01/02/2002 | EP1165754A1 Pharmaceutical compositions comprising circulating blood cells, preferably monocytes and uses thereof |
| 01/02/2002 | EP1165602A1 49 human secreted proteins |
| 01/02/2002 | EP1165598A1 Hookworm platelet inhibitor |
| 01/02/2002 | EP1165590A1 49 human secreted proteins |
| 01/02/2002 | EP1165586A1 TCL-1b GENE AND PROTEIN AND RELATED METHODS AND COMPOSITIONS |
| 01/02/2002 | EP1165573A1 Compounds selectively inhibiting gamma 9 delta 2 t lymphocytes |
| 01/02/2002 | EP1165185A2 Human tumor necrosis factor receptor-like 2 |
| 01/02/2002 | EP1165143A2 Method for expressing proteins |
| 01/02/2002 | EP1165133A1 Anti-human mitochondrial adenylate kinase isozyme antibody, diagnostic formulation and diagnostic kit for cardiac disease |
| 01/02/2002 | EP1165113A2 USE OF ErbB RECEPTOR LIGANDS IN TREATING DIABETES |
| 01/02/2002 | EP1165109A1 Treatment of autoimmune disease |
| 01/02/2002 | EP1165106A2 Composition and method for inducing apoptosis in prostate cancer cells |
| 01/02/2002 | EP1165104A1 Lactic acid bacteria strains capable of preventing diarrhoea |
| 01/02/2002 | EP1165103A1 Pharmaceutical and animal fodder comprising fermented fish |
| 01/02/2002 | EP1165102A1 Matrix protein compositions for grafting |
| 01/02/2002 | EP1165101A2 Induction of antigen-specific unresponsiveness by glioblastoma culture supernatants (gcs) |
| 01/02/2002 | EP1165100A2 Methods of treating schizophrenia |
| 01/02/2002 | EP1165096A2 Use of cytidine derivatives for the treatment of leukaemia |
| 01/02/2002 | EP1165059A1 Pharmaceutical compositions comprising troponin subunits, fragments and homologs thereof and methods of their use to inhibit angiogenesis |
| 01/02/2002 | EP1164863A1 Pet food for maintenance of joint health and alleviation of arthritic symptoms in companion animals |
| 01/02/2002 | EP1121930A4 Drug preparation "histochrome" for treating acute myocardial infarction and ischaemic heart diseases |
| 01/02/2002 | CN1329509A Adeno-associated vectors for expression of factor VIII target cells |
| 01/02/2002 | CN1329501A Therapeutic agent for suppression of snoring noises |
| 01/02/2002 | CN1329500A Anti-dandruff composition comprising antifungal polypeptide |
| 01/02/2002 | CN1328849A Medicine for curing cancers and its preparation method |
| 01/02/2002 | CN1328843A Chinese medicine oral preparation for curing apoplectic disease-Suyusan and its preparation method |
| 01/02/2002 | CN1328841A Medicine for preventing and curing asteoporosis and promoting union and its production method |
| 01/02/2002 | CN1328836A Ointment for curing hemorrhoids |
| 01/02/2002 | CN1328834A Capsule for curing cholecystitis |
| 01/02/2002 | CN1328831A Bone-strengthening powder and its preparation method |
| 01/02/2002 | CN1328828A Plaster for curing external hemorrhoids |
| 01/02/2002 | CN1076971C Powder for removing infantile malnutrition |
| 01/01/2002 | US6335433 nrdD |
| 01/01/2002 | US6335195 Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation |
| 01/01/2002 | US6335181 Generating polypeptide; for use in the diagnosis, prevention and treatment of bacterial infection |
| 01/01/2002 | US6335009 Enhancing sensitivity of cancer tumor cell to dna damaging agent or irradiation by delivering promoter linked to a poly (adp-ribose)-polymerase encoding polynucleotide |
| 01/01/2002 | CA2288677C Novel powder compositions |
| 12/29/2001 | CA2351904A1 Target |
| 12/27/2001 | WO2001098516A2 Siderophores-producing bifidobacteria thereby and uses thereof |
| 12/27/2001 | WO2001098482A2 Liver-specific gene expression cassettes, and methods of use |
| 12/27/2001 | WO2001098481A2 Renal regulatory elements and methods of use thereof |
| 12/27/2001 | WO2001098357A2 Compositions and methods of monoclonal and polyclonal antibodies specific for t cell subpopulations |
| 12/27/2001 | WO2001098344A2 Angiogenesis-modulating compositions and uses |
| 12/27/2001 | WO2001098286A1 Nitrosated and nitrosylated taxanes, compositions and methods of use |
| 12/27/2001 | WO2001097872A1 Bioadhesive compositions and methods of preparation and use |
| 12/27/2001 | WO2001097838A2 Adjuvants and processes to induce a specific type of immune response |
| 12/27/2001 | WO2001097835A1 Matrix protein compositions for inhibition of epithelial cell growth |
| 12/27/2001 | WO2001097834A1 Matrix protein compositions for dentin regeneration |
| 12/27/2001 | WO2001097822A1 Probiotics in primary prevention of atopic diseases |
| 12/27/2001 | WO2001097821A1 Immunotherapy or treating bacterial or viral infection at mucosal surfaces with probiotics, and compositions therefor. |
| 12/27/2001 | WO2001097820A2 Kefir as a potent anti-oxidant composition |
| 12/27/2001 | WO2001068811A3 Method for in vitro production of three-dimensional vital cartilage or bone tissue and use thereof as transplant material |
| 12/27/2001 | WO2001062086A8 Nutritional intervention composition for enhancing and extending satiety |
| 12/27/2001 | WO2001059088A3 Vector |
| 12/27/2001 | WO2001053505A3 Herpes virus strains for gene therapy |
| 12/27/2001 | WO2001051608A3 Hybrid cells obtainable from antigen presenting cells |
| 12/27/2001 | US20010056118 Induction of polymerization of tubulin and the stabilization of microtubules in cells by administering to the cancer cells an effective amount of dictyostatin-1 or derivatives or salt |
| 12/27/2001 | US20010056061 Eliminate the Bovine Spongiform Encephalopathy (BSE) risk by synthesizing a thymic peptide; short-chain peptides with a weighted quantity ratio and a pattern of amino acids characteristic of thymus tissue |
| 12/27/2001 | US20010055745 Method and device for preparing a dental implant by immersion in a culture of mesenchymal cells |
| 12/27/2001 | US20010055590 Method for enhancing myoblast migration and invasion in the context of gene therapy |
| 12/27/2001 | US20010055588 Mixing a biodegradable, biocompatible hydrogel solution such as calcium alginate with dissociated cells and implanting the mixture into the animal; gels provide three-dimensional scaffolds |
| 12/27/2001 | US20010055587 Transplantation of neural cells for the treatment of chronic pain or spasticity |
| 12/27/2001 | US20010055586 Methods and means for targeted gene delivery |
| 12/27/2001 | US20010055583 Methods of preventing aggregation of various substances upon rehydration or thawing and compositions obtained thereby |
| 12/27/2001 | US20010054574 Coal tar extract with a reduced content of hydrocarbons and dermatological and cosmetic compositions containing the same |
| 12/27/2001 | CA2417687A1 Kefir as a potent anti-oxidant composition |